If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board Appointments

18 Jan 2023 07:00

RNS Number : 0474N
Plant Health Care PLC
18 January 2023
 

18 January 2023

 

PLANT HEALTH CARE plc 

("Plant Health Care" or the "Company")

 

Board Appointments

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel peptides for plant protection to global agriculture markets, is pleased to announce the appointments of Kate Coppinger and James Ede-Golightly as Non-Executive Directors.

Kate Coppinger is an experienced Non-Executive Director with an extensive background in investment banking and transaction execution. Having started her career as a research analyst at CIBC World Markets, she joined Harrison Lovegrove in 2000 and continued in her role, which focused on M&A transactions, within Standard Chartered Bank until 2020 following its acquisition of Harrison Lovegrove in 2007.

James Ede-Golightly has over twenty years of experience as a professional investor and director of growth companies. His current roles include Executive Chairman of Oxehealth and Non-Executive Director of Silence Therapeutics Plc. He co-founded Ora Capital Partners in 2006 having been an analyst at Commerzbank AG and Merrill Lynch Investment Managers. James previously served as a Non-Executive Director of Plant Health Care, between June 2013 and November 2016.

 

Chris Richards, Non-Executive Chairman of Plant Health Care, commented:

"We are delighted Kate has joined the Board. Her background in M&A and regulated industries will be an asset in terms of the Company's future product development and geographic expansion.

"In addition, it is great to welcome James back to the Company to help us capture the growth opportunities that we have identified.

"Maintaining the right balance of skills and experience on the Board is one of the keys to our continued progress. These appointments strengthen the Company and we look forward to working with Kate and James as we deliver our exciting growth proposition."

 

For further information, please contact:

 

Plant Health Care plc

Jeffrey Tweedy, Chief Executive Officer

Tel: +1 919 926 1600

Jeffrey Hovey, Chief Financial Officer

 

Cenkos Securities plc - Nomad & Broker

Neil McDonald / Pete Lynch

 

 

Tel: + (0) 131 220 9771

 

SEC Newgate (Financial Communications)

Tel:+44 (0)7540 10666

Robin Tozer / George Esmond

Email: phc@secnewgate.co.uk

 

 

The following information regarding the appointment of Kate Coppinger and James Ede-Golightly is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies:

Full Name:

Katherine Jane Coppinger

Age:

52

Shareholding in the Company:

-

 Current Directorship / Partnerships:

 iGas Energy plc

The Barnes Fund Trustee Limited

Serica Energy plc

Previous Directorship / Partnerships:

-

 

Full Name:

James Lawrence Ede-Golightly

Age:

43

Shareholding in the Company:

625,608 ordinary shares

Current Directorship / Partnerships:

Dunheved Limited

East Balkan Properties Plc

Guernsey Chamber of Commerce

Ora Global Ltd

Oxeco Limited

Oxehealth Limited

Sarossa Plc

Serendipity Capital Limited

Silent Therapeutics Plc

Previous Directorship / Partnerships:

DeepMatter Group Plc

Fermain Capital Limited

Gulfsands Petroleum Plc

Ora Limited

Oxford Advanced Surfaces Ltd

Quoram Limited (previously Quoram Plc)

 

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

About Plant Health Care plc

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADBGDBDXBDGXR
Date   Source Headline
29th Nov 201312:12 pmRNSDirector's Shareholding
25th Nov 20133:15 pmRNSDivestment of non-core subsidiary
18th Oct 20135:00 pmRNSTR-1 Notification of Major Interest in Shares
30th Sep 20135:00 pmRNSTotal Voting Rights
23rd Sep 201310:30 amRNSDirector/PDMR Shareholding
19th Sep 20137:00 amRNSAppointment of Adviser
18th Sep 20133:15 pmRNSDirector/PDMR Shareholding
16th Sep 20137:03 amRNSDirectorate Change
16th Sep 20137:00 amRNSHalf Yearly Report
19th Aug 20132:30 pmRNSBlocklisting Interim Review
30th Jul 20137:01 amRNSUpdate on Harpin
30th Jul 20137:00 amRNSPHC announces plans for Harpin seed treatment
22nd Jul 201311:00 amRNSPHC hires Glen Donald as VP Business Development
19th Jul 20137:00 amRNSHead Office Relocation,Research Facility Expansion
15th Jul 20135:15 pmRNSDirector/PDMR Shareholding
5th Jul 20137:00 amRNSUpdate on CISX Listing
3rd Jul 20137:00 amRNSNew Long-Term Incentive Plan and Grant of Awards
7th Jun 20134:15 pmRNSDirectorate Change
31st May 201311:30 amRNSTotal Voting Rights
21st May 201312:00 pmRNSHarpin Granted Federal Registration in Mexico
10th May 20134:45 pmRNSDirector/PDMR Shareholding
9th May 20131:20 pmRNSDirectorate Change
9th May 20131:20 pmRNSResult of AGM
7th May 201310:00 amRNSDirector/PDMR Shareholding
3rd May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSTotal Voting Rights
25th Apr 20137:00 amRNSPHC and Arysta LifeScience sign license agreement
19th Apr 20133:30 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:33 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
16th Apr 20138:23 amRNSRe. Investment
15th Apr 20131:30 pmRNSResult of General Meeting
8th Apr 20135:45 pmRNSPublication of Annual Report and Notice of AGM
2nd Apr 20137:00 amRNSConfirmation of Board Changes
27th Mar 20137:00 amRNSPosting of Circular to Shareholders
26th Mar 20134:19 pmRNSBoard Changes
26th Mar 20134:19 pmRNSPlacing and Subscription
26th Mar 20134:18 pmRNSFinal Results
20th Mar 201311:35 amRNSPHC reaches milestone agreement with Germains
11th Mar 20137:00 amRNSMarket Update
19th Feb 20135:45 pmRNSBlock Listing Six-Monthly Return
24th Jan 20139:30 amRNSHarpin field trials results
18th Jan 20135:00 pmRNSNotification of Major Interest in Shares
10th Jan 201312:45 pmRNSTrading Update
31st Dec 201212:25 pmRNSTotal Voting Rights
30th Nov 201211:45 amRNSTotal Voting Rights
2nd Nov 201212:15 pmRNSNotification of Major Interest in Shares
23rd Oct 20127:00 amRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.